We examined the expression of Polycomb group (PcG) target genes in BOS and AML-ASXL1 samples to determine whether these genes were differentially expressed in the context of ASXL1 mutations (Table S3). This evidence concerns the gene ASXL1 and acute myeloid leukemia.